Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2024-06-25 00:00:00 ET · period of report 2024-06-21 · accession 0000950170-24-077522 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2024-06-25 | 2024-06-25 | SRPT | Brown Ryan Edward | EVP, GC | S - Sale+OE | $161.61 | -39.0K | 23.5K | -62% | -$6.30M |
| DMT | 2024-06-25 | 2024-06-21+ | SRPT | Brown Ryan Edward | EVP, GC | M - OptEx | $62.77 | +29.8K | 34.9K | +573% | +$1.87M |
| DT | 2024-06-25 | 2024-06-24 | SRPT | Brown Ryan Edward | EVP, GC | F - Tax | $164.64 | -2,352 | 32.6K | -7% | -$387.2K |
| DMT | 2024-06-25 | 2024-06-21+ | SRPT | Brown Ryan Edward | EVP, GC | M - OptEx | $0.00 | -29.8K | 0 | -100% | $0 |
| DMT | 2024-06-25 | 2024-06-21 | SRPT | Brown Ryan Edward | EVP, GC | A - Grant | $0.00 | +11.8K | 6,250 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-25 | S | D | 2,549 | $164.52 | 17,129 | D | — | — | (F3) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2024. |
| 2 | Common | Common Stock | 2024-06-25 | M | A | 23,500 | $62.77 | 56,086 | D | — | — | |
| 3 | Common | Common Stock | 2024-06-21 | M | A | 6,250 | — | 34,938 | D | — | — | (F1) Represents the number of shares earned and vested under a performance stock unit ("PSU") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. |
| 4 | Common | Common Stock | 2024-06-24 | F | D | 2,352 | $164.64 | 32,586 | D | — | — | (F2) Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 1, 2024. |
| 5 | Common | Common Stock | 2024-06-25 | S | D | 3,840 | $163.53 | 19,678 | D | — | — | (F3) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2024. (F9) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.19 to $163.98 inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| 6 | Common | Common Stock | 2024-06-25 | S | D | 7,644 | $158.07 | 48,442 | D | — | — | (F3) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2024. (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.58 to $158.52, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| 7 | Common | Common Stock | 2024-06-25 | S | D | 2,200 | $159.14 | 46,242 | D | — | — | (F3) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2024. (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.67 to $159.66, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| 8 | Common | Common Stock | 2024-06-25 | S | D | 975 | $160.31 | 45,267 | D | — | — | (F3) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2024. (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.71 to $160.69, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| 9 | Common | Common Stock | 2024-06-25 | S | D | 4,168 | $161.82 | 41,099 | D | — | — | (F3) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2024. (F7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.04 to $162.02, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| 10 | Common | Common Stock | 2024-06-25 | S | D | 17,581 | $162.65 | 23,518 | D | — | — | (F3) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2024. (F8) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.12 to $163.09, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| 11 | Derivative | Stock Option (right to buy) | 2024-06-25 | M | D | 23,500 | $0.00 | 0 | D | $62.77 · 2019-02-28 to 2028-02-28 | 23,500 Common Stock | |
| 12 | Derivative | Performance Stock Units | 2024-06-21 | A | A | 5,500 | $0.00 | 5,500 | D | — · — to — | 5,500 Common Stock | (F10) Represents the number of shares earned under a PSU award granted to the Reporting Person on March 7, 2022. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 7, 2025, subject to the Reporting Person continuing to provide service to the Company through such vesting date. |
| 13 | Derivative | Performance Stock Units | 2024-06-21 | A | A | 6,250 | $0.00 | 6,250 | D | — · — to — | 6,250 Common Stock | (F1) Represents the number of shares earned and vested under a performance stock unit ("PSU") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. |
| 14 | Derivative | Performance Stock Units | 2024-06-21 | M | D | 6,250 | $0.00 | 0 | D | — · — to — | 6,250 Common Stock | (F1) Represents the number of shares earned and vested under a performance stock unit ("PSU") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. |